Natalyn Hawk

Mohamed F Jalloh 1 collaboration

Paul Sengeh 1 collaboration

Rebecca E Bunnell 1 collaboration

Mohammad B Jalloh 1 collaboration

Roeland Monasch 1 collaboration

Wenshu Li 1 collaboration

Jonathan Mermin 1 collaboration

Nickolas DeLuca 1 collaboration

Vance Brown 1 collaboration

Sophia A Nur 1 collaboration

Euna M August 1 collaboration

Ray L Ransom 1 collaboration

Apophia Namageyo-Funa 1 collaboration

Sara A Clements 1 collaboration

Meredith Dyson 1 collaboration

Kathy Hageman 1 collaboration

Samuel Abu Pratt 1 collaboration

Azizeh Nuriddin 1 collaboration

Dianna D Carroll 1 collaboration

Nicole Hawk 1 collaboration

Craig Manning 1 collaboration

Sara Hersey 1 collaboration

Barbara J Marston 1 collaboration

Peter H Kilmarx 1 collaboration

Lansana Conteh 1 collaboration

Anna Mia Ekström 1 collaboration

Zangin Zeebari 1 collaboration

John T Redd 1 collaboration

Helena Nordenstedt 1 collaboration

Oliver Morgan 1 collaboration

Ana Arance 1 collaboration

Luis de la Cruz-Merino 1 collaboration

Teresa M Petrella 1 collaboration

Rahima Jamal 1 collaboration

Lars Ny 1 collaboration

Ana Carneiro 1 collaboration

Alfonso Berrocal 1 collaboration

Ivan Márquez-Rodas 1 collaboration

Anna Spreafico 1 collaboration

Victoria Atkinson 1 collaboration

Fernanda Costa Svedman 1 collaboration

Andrew Mant 1 collaboration

Muhammad A Khattak 1 collaboration

Catalin Mihalcioiu 1 collaboration

Sekwon Jang 1 collaboration

C Lance Cowey 1 collaboration

Alan D Smith 1 collaboration

Ke Chen 1 collaboration

Scott J Diede 1 collaboration

Clemens Krepler 1 collaboration

Georgina V Long 1 collaboration

Affiliations

Publications (2)

Evidence of behaviour change during an Ebola virus disease outbreak, Sierra Leone.

Phase II LEAP-004 Study of Lenvatinib Plus Pembrolizumab for Melanoma With Confirmed Progression on a Programmed Cell Death Protein-1 or Programmed Death Ligand 1 Inhibitor Given as Monotherapy or in Combination.

Réseau de co-auteurs